Madigan Catherine bought COAG
January 29, 2026 · Form 4 insider transaction
Madigan Catherine bought 145,134 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 95 days after the transaction.
Direction
Acquired (buy-side)
Shares
145,134
Price
$0.00
Total value
N/A
InsiderMadigan Catherine
RoleOfficer
SecurityWarrants (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2026
Filing dateMay 4, 2026
Shares owned after145,134
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The warrant was granted on January 29, 2026. The shares underlying the warrant vest over four years, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal monthly installments thereafter.